drugset / Trial / NCT00722436

Tranexamic Acid for Craniofacial Surgery

NCT00722436 ↗

Phase 4 Terminated 20 enrolled University of Pittsburgh
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, blinded, prospective study that will investigate the potential benefit of tranexamic acid to reduce the intraoperative bleeding and blood transfusions in pediatric patients undergoing craniofacial surgeries.

Timeline

Start
2008-07
Primary completion
2012-06
Completion
2012-06

Outcome

Outcome not reported

Stopped: “Study dose changed based on recent publications”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous